Saunders & S
At present, several oral antidiabetic medications are used for the treatment of T2DM including, -glucosidases inhibitors, biguanides, sulfonylureas, meglitinides, GLP-1 receptor agonists (GLP-1RAs), peroxisome proliferator-activated receptor (PPAR-) agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and sodiumglucose transporter 2 (SGLT2) inhibitors
Mountain communities are a different story
Regular treatments can improve skin elasticity, reduce fine lines and wrinkles, and promote collagen production
Tirzepatide : As a dual agonist, Tirzepatide not only targets GLP-1 receptors but also engages other receptors involved in blood sugar regulation, making it an attractive choice for those seeking comprehensive metabolic support